Search results
Showing 1461 to 1470 of 4159 search results for Blue Insurance.
-
Guaranteed Loans (clone of FCA authorised firm)
We have published this statement in order to warn consumers against dealing with unauthorised firms. -
FSA Commentary on FSA Complaints Data 2006 to 2008 [pdf]
FSA commentary on FSA Aggregate Complaints Data 2006 - 2008 including highlights. -
Carbon credit trading scams
Find out how carbon credit trading works, how to avoid scams and what to do if you’re scammed. -
MS18/1.2: Annex 2: Business models and financial analysis technical annex [pdf]
This annex presents the financial analysis of firms in the motor and home insurance markets conducted as part of the market study. This annex is part of the General Insurance Pricing Practices Market Study Interim Report. -
Andreas Braasch (clone of FCA authorised firm)
Fraudsters are using the details of firms we authorise to try to convince people that they work for a genuine, authorised firm. Find out more about this 'clone firm'. -
My-PersonalLoan (clone of FCA authorised firm)
Fraudsters are using the details of firms we authorise to try to convince people that they work for a genuine, authorised firm. Find out more about this 'clone firm'. -
The coronavirus (Covid-19) financial resilience survey data
The results from the FCA's financial resilience surveys that were sent to 23,000 regulated firms. Through the surveys the FCA is understanding the real-time effect the pandemic is having on the finances of the firms it prudentially regulates. -
LoanAxess Limited (clone of FCA authorised firm)
Fraudsters are using the details of firms we authorise to try to convince people that they work for a genuine, authorised firm. Find out more about this 'clone firm'. -
International standards and regulations
A large part of the FCA's work is to implement, supervise and enforce international standards and regulations in the UK. -
MS18/1.2: Annex 6: Future trends in general insurance pricing research report [pdf]
The FCA asked Deloitte to identify the emergence of new business models and review their potential impact on pricing to understand the implications on potential remedies from the pricing review. This annex is part of the General Insurance Pricing